Eisai
4523.T
#2105
Rank
HK$53.88 B
Marketcap
HK$191.00
Share price
-4.47%
Change (1 day)
-37.55%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): HK$3.42 Billion

According to Eisai's latest financial reports the company's current earnings are HK$5.06 Billion. In 2023 the company made an earning of HK$4.06 Billion, an increase over its 2022 earnings that were of -HK$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$3.42 B-15.67%
2023 HK$4.06 B-2392.87%
2022 -HK$0.18 Billion-103.6%
2021 HK$4.92 B-39.52%
2020 HK$8.14 B7.3%
2019 HK$7.58 B17.23%
2018 HK$6.47 B86.06%
2017 HK$3.47 B-23.64%
2016 HK$4.55 B27.28%
2015 HK$3.57 B22.08%
2014 HK$2.93 B-46.11%
2013 HK$5.44 B-21.67%
2012 HK$6.94 B-20.72%
2011 HK$8.76 B-8.44%
2010 HK$9.56 B18.85%
2009 HK$8.05 B